Enhanced Ultrasound-Enhanced Drug Delivery System

An improved system and method for ultrasound-enhanced delivery of drugs to intraocular spaces, featuring advancements in handheld devices, machine learning-based optimization, novel materials, and real-time tracking.

The original patent, 'System and method for ultrasound-enhanced delivery of drugs,' has limitations in terms of device complexity, user interface, and efficacy. The new inventive concept addresses these limitations by introducing a handheld, user-friendly device with integrated drug reservoir and real-time monitoring capabilities, as well as machine learning-based optimization of ultrasound parameters and novel ultrasound-transparent materials.

The enhanced system comprises a handheld ultrasound-generating device with an integrated drug reservoir and a user interface for real-time monitoring of drug delivery. The device is designed for ease of use and portability, allowing for more efficient and effective treatment of various ophthalmic diseases. The system also incorporates machine learning algorithms to optimize ultrasound parameters for enhanced drug delivery to target sites in intraocular spaces. Additionally, the drug applicator features a novel ultrasound-transparent material that minimizes attenuation of ultrasound waves, thereby increasing the efficacy of drug delivery. The system can be programmed to deliver multiple drugs to different target sites in an intraocular space, and real-time tracking of drug delivery is enabled through the use of ultrasound imaging and a contrast agent.

The new claims introduce several novel and non-obvious features, including the handheld, integrated device design, machine learning-based optimization of ultrasound parameters, and the use of novel ultrasound-transparent materials. These advancements provide significant improvements over the original patent, offering enhanced efficacy, ease of use, and real-time monitoring capabilities.

Alternative embodiments of the inventive concept could include variations in device design, such as wearable or implantable devices, or the use of different machine learning algorithms or optimization techniques. Additionally, the system could be adapted for use in other medical applications beyond ophthalmology.

The enhanced ultrasound-enhanced drug delivery system has significant commercial potential in the ophthalmic industry, with applications in the treatment of various diseases and conditions, including central retinal vein occlusion, branch retinal vein occlusion, and uveitis. The market for ophthalmic treatments is growing rapidly, driven by an aging population and increasing prevalence of eye diseases.